EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma Meeting Abstract


Authors: Hoimes, C. J.; Rosenberg, J. E.; Srinivas, S.; Petrylak, D. P.; Milowsky, M.; Merchan, J. R.; Bilen, M. A.; Gupta, S.; Carret, A. S.; Yuan, N.; Melhem-Bertrandt, A.; Flaig, T.
Abstract Title: EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
Meeting Title: 44th ESMO Congress (ESMO 2019)
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 5
Meeting Dates: 2019 Sep 27-Oct 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-10-01
Start Page: mdz249
Language: English
ACCESSION: WOS:000491295502328
PROVIDER: wos
DOI: 10.1093/annonc/mdz249
Notes: Meeting Abstract: 901O -- Appears on page v356 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg